Gilpin Wealth Management LLC Acquires New Position in Invesco Pharmaceuticals ETF $PJP

Gilpin Wealth Management LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 7,030 shares of the company’s stock, valued at approximately $735,000. Gilpin Wealth Management LLC owned about 0.18% of Invesco Pharmaceuticals ETF as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the business. LPL Financial LLC grew its position in shares of Invesco Pharmaceuticals ETF by 5.6% during the 4th quarter. LPL Financial LLC now owns 59,366 shares of the company’s stock valued at $6,206,000 after buying an additional 3,156 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its position in shares of Invesco Pharmaceuticals ETF by 829.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 25,941 shares of the company’s stock valued at $2,712,000 after buying an additional 23,150 shares during the last quarter. Ameriprise Financial Inc. grew its position in shares of Invesco Pharmaceuticals ETF by 214.4% during the 3rd quarter. Ameriprise Financial Inc. now owns 12,236 shares of the company’s stock valued at $1,114,000 after buying an additional 8,344 shares during the last quarter. BNP Paribas Financial Markets bought a new stake in shares of Invesco Pharmaceuticals ETF during the 2nd quarter valued at about $799,000. Finally, Flagship Harbor Advisors LLC grew its position in shares of Invesco Pharmaceuticals ETF by 1.8% during the 4th quarter. Flagship Harbor Advisors LLC now owns 6,049 shares of the company’s stock valued at $632,000 after buying an additional 105 shares during the last quarter.

Invesco Pharmaceuticals ETF Stock Down 0.2%

Shares of NYSEARCA:PJP opened at $111.77 on Thursday. Invesco Pharmaceuticals ETF has a fifty-two week low of $78.77 and a fifty-two week high of $113.20. The firm has a 50-day simple moving average of $106.47 and a 200 day simple moving average of $106.02. The company has a market cap of $365.49 million, a PE ratio of 15.59 and a beta of 0.46.

Invesco Pharmaceuticals ETF Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.